ClinicalTrials.gov
ClinicalTrials.gov Menu

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01137981
Recruitment Status : Recruiting
First Posted : June 7, 2010
Last Update Posted : October 24, 2017
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2024
  Estimated Study Completion Date : December 31, 2024
Publications:
The Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy registry International Interim report for 1 January 1989 through 31 January 2010. Wilmington, NC: Registry Coordinating Center; 2010. Available from URL: www.APRegistry.com

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):